SNTI

Senti Biosciences Holdings, Inc.

NasdaqHealthcareBIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)

Insider activity for last month from Oct 16 to Nov 16.

How these metrics are calculated

Counts use processed Form 4 rows. Purchase and sale metrics use codes P and S; totals remain unknown when any matching value is missing. Rows without a usable transaction date cannot be assigned to a rolling period and are excluded.

Total buying$00 buys
Total selling$00 sales
Net open-market$0Buying minus selling
Active insiders2Distinct reporting owners

SNTI transaction history

Newest filings · 20 transactions per page

Latest insider transactions

Form 4 filings from last month.
Newest company filings
InsiderActivityDisclosed valueFiled (ET)
Rajangam Kanya
President · CM · DO
PRES, CM, DO
Tax withholding
Form 4 code F. Payment of an exercise price or tax liability by delivering or withholding securities in a Rule 16b-3 transaction.
Large disposal
Units disposed were at least 25% of reported post-transaction holdings.
SEC filing ↗
$0View disclosure →
Lu Timothy K
CEO
CEO. Role codes can represent multiple titles; the list does not include the filing title.
Tax withholding
Form 4 code F. Payment of an exercise price or tax liability by delivering or withholding securities in a Rule 16b-3 transaction.
Large disposal
Units disposed were at least 25% of reported post-transaction holdings.
SEC filing ↗
$0View disclosure →

Insider activity report

Calendar-month buckets within the selected date range

Latest filing: Oct 23, 2026

Open-market transaction mix · 0 transactions in the selected period

Code A includes awards, grants and other acquisitions; these are not open-market buys. A rolling period can include partial calendar months.

View exact monthly counts and disclosed values
Monthly activity within the selected period; unknown values remain unknown.
MonthBuysSellsAwards (A)Buy valueSell valueNet P/S value
Oct 2026000$0$0$0
Nov 2026000$0$0$0

Distinct insiders active

Reporting-owner CIKs by month · peak Oct 2026 (2)
Oct 2026: 2 insidersNov 2026: 0 insiders
Oct 2026Nov 2026
2distinct insiders in selected period
Largest insider activity
By absolute net disclosed value · current transaction page
2 insiders
  • RK
    Rajangam KanyaPRES, CM, DO · 0 buys · 0 sales · 0 awards (A)
    $0last Oct 23
  • LK
    Lu Timothy KCEO · 0 buys · 0 sales · 0 awards (A)
    $0last Oct 23
Filing, role and holdings details

Filing-only signals

Deterministic matches in the selected period

Recent filing activity
Most recent 2 transactions on this page · color = transaction code
  • FTax withholdingOct 23
    SNTI · Senti Biosciences Holdings, Inc. · Rajangam Kanya · PRES, CM, DO
    $0trade Oct 21SEC
  • FTax withholdingOct 23
    SNTI · Senti Biosciences Holdings, Inc. · Lu Timothy K · CEO
    $0trade Oct 21SEC

Filing detail checks

Secondary metrics for the selected period
Largest buy—
Largest sale—
10b5-1 detected0
Amended rows0

Transaction codes

By Form 4 transaction code in selected period
2transactionstxns
  • F · Tax withholding · dominant2 · 100%

Activity by reported role

A joint filing can contribute to multiple roles
Chief executive officer1
CM1
DO1
PRES1

Reported Holdings After

Separated by insider, security, and ownership type

Lu Timothy KCommon Stock · Direct
482k482kOct 21, 2026Oct 21, 2026
482,271Oct 21, 2026
Rajangam KanyaCommon Stock · Direct
54.9k54.9kOct 21, 2026Oct 21, 2026
54,890Oct 21, 2026

These are reported post-transaction holdings, not company-wide ownership percentages. Securities, indirect vehicles, and amendments are kept separate.

Filing activity heatmap
Current transaction page only · each cell is a filing date · buys green, sells red
1 active days
Oct 16 → Nov 16
LessMore

Senti Biosciences Holdings, Inc. Insider Activity FAQ

SEC Form 4 context

Who recently reported transactions at Senti Biosciences Holdings, Inc.?

Rajangam Kanya, Lu Timothy K.

When was the latest reported open-market purchase?

No code-P purchase is available for this period.

When was the latest reported open-market sale?

No code-S sale is available for this period.

What is the recent purchase and sale balance?

No code-P purchases or code-S sales were reported in the selected period.

Where can I see the original SEC filing?

Every transaction row and latest-activity fact links to its original SEC filing.

What do these Form 4 transaction codes mean?

P and S generally describe open-market or private purchases and sales. A, D, F, M, X, G, J, and V describe awards, issuer dispositions, tax withholding, exercises, gifts, other transactions, and voluntary early reports; review each filing and its footnotes for context.